Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03234660Completed
Randomised, double-blind trial of dexmedetomidine in anesthesia-induced neurotoxicity (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Glial Fibrillary Acidic Protein. Started Sep 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03234660.